R&D Applying genetics to chemistry to find new small molecules For all the advances that have been made in it, drug discovery is still a hit or miss process, as much an art as a science.
News After rebuffing Biogen, Sage pairs off with Supernus Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
